Malmö, Sweden

Anna Karin Morén

This inventor holds 2 USPTO granted patents and 3 published patent applications and 3 EPO patents. Top assignee: Galenica Ab. Active years: 2014-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anna Karin Morén. Retrieved from https://idiyas.com/inventor/anna-karin-morén

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2014-2022

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Anna Karin Morén

Introduction

Anna Karin Morén is a notable inventor based in Malmö, Sweden. She has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compositions that enhance therapeutic effects. With a total of 2 patents, her work is recognized for its innovative approach to drug formulation.

Latest Patents

Among her latest patents is the "Oil-in-water emulsion of mometasone and propylene glycol." This invention presents a novel pharmaceutical composition of mometasone or a pharmaceutically acceptable derivative in the form of an oil-in-water emulsion, notably a cream. The composition boasts excellent stability and therapeutic effect. It contains mometasone in micronized form, propylene glycol, and water, with a weight ratio between the propylene glycol and water ranging from 1:1 to about 1:3. This formulation is designed to improve the delivery and efficacy of the medication.

Career Highlights

Anna Karin Morén has established herself as a key figure in her field through her innovative research and development efforts. Her work at Galenica AB has allowed her to focus on creating effective pharmaceutical solutions that address various medical needs.

Collaborations

One of her notable collaborators is Henri Hansson, with whom she has worked closely to advance their shared goals in pharmaceutical innovation.

Conclusion

Anna Karin Morén's contributions to the pharmaceutical industry exemplify the impact of innovative thinking in drug formulation. Her patents reflect a commitment to improving therapeutic outcomes through scientific advancement.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…